William Blair updates conviction list: Oracle in, Meta out and more
at seekingalpha.com (Wed, 1-Jul 7:26 AM)
FDA Green Light for AUVELITY Marks a New Era for Alzheimer's Agitation—AXSM Highlights First-in-Class Approval at Investor Event
Market Chameleon (Mon, 4-May 10:33 AM)
Axsome's Q1 2026: 57% Revenue Growth and AUVELITY Approval Signal Expanding Strength in CNS Treatments
Market Chameleon (Mon, 4-May 8:36 AM)
Axsome Therapeutics Sets May 4 Release for Q1 2026 Results—Investors Await Updates on CNS Drug Pipeline
Market Chameleon (Wed, 8-Apr 9:35 AM)
